Viscosupplementation Market Size - By Product (Single Injection, 3 Injections, 5 Injections), By Source of Origin (Avian Origin, Non-avian Origin), By End-use (Hospitals, Ambulatory Surgical Centers), & Forecast, 2023 – 2032

Viscosupplementation Market Size - By Product (Single Injection, 3 Injections, 5 Injections), By Source of Origin (Avian Origin, Non-avian Origin), By End-use (Hospitals, Ambulatory Surgical Centers), & Forecast, 2023 – 2032

Viscosupplementation Market Size

Viscosupplementation Market size was worth USD 3.6 billion in 2022. Driven by the high prevalence of osteoarthritis among the aging population, the industry is poised to record more than 9% CAGR from 2023 to 2032.

Geriatric people are more susceptible to various health conditions, including osteoarthritis due to age-related changes in the body, such as diminished cartilage repair ability and changes in joint structure, which contribute to the disease's development and progression. In recent years, viscosupplementation has emerged as a popular treatment option for managing symptoms and improving joint function. The technique has a high acceptance rate among patients who have not received adequate relief from conservative therapies, promoting market expansion.

Besides, scientists and researchers worldwide have been working on prospects and undertaking efforts to enhance the molecular structure and characteristics of hyaluronic acid. This will help increase its viscosity, durability, and lubricating effects in joints, which, in consequence, will favor the market dynamics.

COVID-19 Impact

The onset of the COVID-19 pandemic had a detrimental influence on the viscosupplementation market revenue in 2020. Increased demand for COVID-19 therapy substantially impacted the treatment of other diseases, including joint pain treatment procedures. However, in 2021, technical advances and the inclusion of telemedicine improved target disease diagnosis and treatment compliance. Furthermore, various hospitals, surgeons, and healthcare authorities undertook measures to reestablish the flow of orthopedic treatments, including joint pain therapy. This apart, declining infection rates and patients and increased procedure volume in the post-pandemic scenario further facilitated market growth.

Viscosupplementation Market Trends

Technological improvements have impacted many aspects of healthcare, including viscosupplementation, over the years. The ongoing efforts toward developing more sophisticated and effective hyaluronic acid formulations for viscosupplementation and the advent of specialized injection devices and instruments that allow accurate and exact medicine delivery has increased product uptake. The market outlook is expected to strengthen as these breakthroughs continue to emerge, providing new opportunities for the innovation of improved treatment that results and better management of joint-related disorders.

Viscosupplementation Market Analysis

The viscosupplementation market from the single injection segment reached around USD 1.4 billion in 2022 and could witness significant growth through 2032 owing to the growing interest in the concept of single injection viscosupplementation. Treatment with a single injection of viscosupplementation involves administering a higher dose of hyaluronic acid in a single injection session which is convenient for the patients. Additionally, several benefits associated with the use of a single injection, such as pain relief, improved joint function, and minimal side effects, have contributed to its growing adoption rate.

The non-avian segment held a dominant share of the viscosupplementation market with revenue of around USD 2.7 billion in 2022. Non-avian sources such as bacterial fermentation or bio-fermentation using GMOs are used to produce hyaluronic acid for medical and therapeutic purposes. Non-avian hyaluronic acid is typically well-tolerated, with few side effects, making it a safer option for controlling joint discomfort, especially when compared to some drugs or invasive surgical treatments, contributing to its growing popularity.

The viscosupplementation market from the hospitals segment garnered over USD 2.2 billion in revenue in 2022. Increasing patient inclination toward treatment that provide improved outcomes has favored segment growth. The increasing patient inflow with orthopedic problems and the availability of trained specialists drive the need for high-quality hyaluronic acid injections at hospitals. Furthermore, these facilities continuously monitor patients after treatments, design workouts to recover strength, work closely with patients, and offer physical therapies. All of this contributes to the rising preference for well-equipped facilities, thereby augmenting segment gains.

North America viscosupplementation market is anticipated to reach around USD 3.4 billion by 2032. This high revenue share is attributed to the rising prevalence of arthritis and other bone-related disorders and the increased acceptance of new products across the region. Furthermore, the rising incidences of orthopedic disorders in the senior population, increasing number of traffic accidents and sports injuries, ongoing treatment innovations, and rising product demand are some of the factors propelling the regional market expansion.

Viscosupplementation Market Share

Some of the major market players operating in the viscosupplementation industry are

• Zimmer Biomet
• OrthogenRX
• Anika Therapeutics, Inc
• Bioventus
   

Viscosupplementation Market News

• In November 2022, a leading joint preservation firm, Anika Therapeutics, Inc., successfully achieved the Phase III Study for Cingal's primary endpoint. This medication is designed to provide long-term pain relief to those suffering from knee osteoarthritis (OA). The company is concentrating on obtaining FDA clearance for the Cingal and its debut in the United States. Such successful trials enable businesses to expand their R&D operations and gain a competitive advantage over their counterparts.
   

Viscosupplementation Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product, 2018 - 2032 (USD Million)

• Single Injection
• 3 Injections
• 5 Injections

Market, By Source of Origin, 2018 - 2032 (USD Million)

• Avian Origin
• Non-avian Origin

Market, By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Iran